THE WANAMAKER BUILDING OFFICE LEASE AGREEMENT BY AND BETWEEN WANAMAKER OFFICE LEASE, LP a Delaware limited partnership (“LANDLORD”) AND TEVOGEN BIO INC a Delaware corporation (“TENANT”) DATED June 9, 2022 OFFICE LEASE AGREEMENT BETWEEN WANAMAKER...Office Lease Agreement • November 22nd, 2023 • Semper Paratus Acquisition Corp • Biological products, (no disgnostic substances) • Pennsylvania
THIS OFFICE LEASE AGREEMENT is made as of the 9th day of June, 2022, (hereinafter referred to as the “Lease”), between WANAMAKER OFFICE LEASE, LP, a Delaware limited partnership, (hereinafter referred to as “Landlord”), and TEVOGEN BIO INC, a Delaware corporation, whose present address is 15 Independence Way, Warren, NJ 07059 (hereinafter referred to as “Tenant”).
SERVICE AGREEMENTService Agreement • November 22nd, 2023 • Semper Paratus Acquisition Corp • Biological products, (no disgnostic substances) • Massachusetts
The licensee(s) identified on the signature block of this agreement (the “Licensee”) and CIC hereby agree to the following (the “Agreement” or “Service Agreement”).
LEASE AGREEMENT BETWEEN Mitsui Sumitomo Insurance Company of America (Landlord) -and- Tevogen Bio Inc. (Tenant)Lease Agreement • November 22nd, 2023 • Semper Paratus Acquisition Corp • Biological products, (no disgnostic substances)
THIS LEASE AGREEMENT (this “Lease”), is made as of the 14th day of February, 2022, (“Effective Date”) by and between Mitsui Sumitomo Insurance Company of America, a New York corporation, having an address at 15 Independence Boulevard, Warren, New Jersey 07059 (“Landlord”), and Tevogen Bio Inc., a Delaware limited liability company having an address at 48 Bridge Street, Metuchen NJ 08840 (“Tenant”).
TEVOGEN BIO INC.Restricted Stock Unit Agreement • November 22nd, 2023 • Semper Paratus Acquisition Corp • Biological products, (no disgnostic substances)
Tevogen Bio Inc., a Delaware corporation (the “Company”), hereby grants restricted stock units (the “RSUs”) relating to shares of the Company’s non-voting common stock, par value $0.01 per share (the “Stock”), to the Grantee named below, subject to the vesting and other conditions set forth below. Additional terms and conditions of the RSUs are set forth in this cover sheet and in the attached Restricted Stock Unit Agreement (together, the “Agreement”) and in the Tevogen Bio Inc. 2020 Equity Incentive Plan (as it has been or may be amended and/or restated from time to time, the “Plan”).
